Deborah Ann Thomas
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 219
- Chronic Lymphocytic Leukemia Research 169
- Myeloproliferative Neoplasms: Diagnosis and Treatment 45
- Hematology 212
- Chronic Myeloid Leukemia Treatments 122
- Acute Myeloid Leukemia Research 101
- Multiple Myeloma Research and Treatments 19
- Co-authors
- Hagop Kantarjian (251 shared papers)Jörge E. Cortes (251 shared papers)Susan Mary O'Brien (202 shared papers)Francis Joseph Giles (118 shared papers)Stefan H Faderl (164 shared papers)Guillermo Garcia‐Manero (154 shared papers)Michael J. Keating (74 shared papers)Srđan Verstovšek (102 shared papers)
- Journals
- Blood (215 papers)Cancer (59 papers)Journal of Clinical Oncology (18 papers)British Journal of Haematology (13 papers)American Journal of Hematology (10 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Deborah Ann Thomas
454 papers receiving 28.6k citations
Deborah Ann Thomas's Hit Papers
Peers
Comparison fields: 5 of 162
- Hematology 13.8k
- Genetics 11.0k
- Pathology and Forensic Medicine 5.5k
- Public Health, Environmental and Occupational Health 7.2k
- Oncology 5.3k
Countries citing papers authored by Deborah Ann Thomas
This map shows the geographic impact of Deborah Ann Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Ann Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Ann Thomas more than expected).
Fields of papers citing papers by Deborah Ann Thomas
This network shows the impact of papers produced by Deborah Ann Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Ann Thomas. The network helps show where Deborah Ann Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Ann Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 467 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion Hit paper breakdown → | 2006 | 1079 |
| 2 | Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis Hit paper breakdown → | 2010 | 992 |
| 3 | Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2005 | 781 |
| 4 | Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies Hit paper breakdown → | 2003 | 702 |
| 5 | 2001 | 617 | |
| 6 | 2000 | 605 | |
| 7 | 2008 | 574 | |
| 8 | Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe Hit paper breakdown → | 2017 | 555 |
| 9 | 2004 | 526 | |
| 10 | 2001 | 510 | |
| 11 | 2003 | 472 | |
| 12 | 2006 | 440 | |
| 13 | 2005 | 434 | |
| 14 | 2003 | 424 | |
| 15 | 2010 | 357 | |
| 16 | 2007 | 356 | |
| 17 | Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study Hit paper breakdown → | 2012 | 355 |
| 18 | 2003 | 332 | |
| 19 | 2010 | 322 | |
| 20 | Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults Hit paper breakdown → | 2016 | 300 |
About Deborah Ann Thomas
Deborah Ann Thomas is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 467 papers that have together received 29.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (192 papers), Chronic Lymphocytic Leukemia Research (169 papers), Chronic Myeloid Leukemia Treatments (122 papers), Acute Myeloid Leukemia Research (101 papers), Lymphoma Diagnosis and Treatment (72 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (45 papers), Childhood Cancer Survivors' Quality of Life (24 papers) and Multiple Myeloma Research and Treatments (19 papers). The work is most often cited by research in Hematology (13.8k citations), Genetics (11.0k citations), Pathology and Forensic Medicine (5.5k citations), Public Health, Environmental and Occupational Health (7.2k citations) and Oncology (5.3k citations). Deborah Ann Thomas has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Hagop Kantarjian, Jörge E. Cortes, Susan Mary O'Brien, Francis Joseph Giles, Stefan H Faderl, Guillermo Garcia‐Manero, Michael J. Keating, Srđan Verstovšek, Maher X. Albitar and Farhad Ravandi. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, British Journal of Haematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.